Share

August 20, 2013; 81 (8) Article

Early seizure onset and dysplastic lesion extent independently disrupt cognitive networks

Brandon Korman, Pavel Krsek, Michael Duchowny, Bruno Maton, Esperanza Pacheco-Jacome, Gustavo Rey
First published July 19, 2013, DOI: https://doi.org/10.1212/WNL.0b013e3182a1aa2a
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
236

Share

Article Information

vol. 81 no. 8 745-751
DOI: 
https://doi.org/10.1212/WNL.0b013e3182a1aa2a
PubMed: 
23873975
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received October 26, 2012
  • Accepted in final form May 10, 2013
  • First Published July 19, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Brandon Korman, PsyD,
    2. Pavel Krsek, MD, PhD,
    3. Michael Duchowny, MD,
    4. Bruno Maton, MD,
    5. Esperanza Pacheco-Jacome, MD and
    6. Gustavo Rey, PhD
  1. Brandon Korman, PsyD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Miami Children's Hospital, Neuropsychologist

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. U. S. Army Medical Research and Materiel Command, W81XWH- 06-1-0663, 2006-Present, Sub-investigator

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Pavel Krsek, MD, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Michael Duchowny, MD,
    4. Scientific Advisory Boards:

    1. (1) Questcor Pharmaceutical, sceintific advisor, 2010

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Ortho-McNeil Pharmaceutical, scientific presentation, 2009

    Editorial Boards:

    1. Journal of Child Neurology, Associate Editor, 1997-present Epilepsia, Associate Editor, 2006-present Faculty of 100 Medicine, Section Editor, 2004-present Pediatric Neurology, Editor, 1997-present Epileptic Disorders, Editor, 1998-present Epilepsy Research and Treatment, Editor, 2009-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. Intractable Focal Epilepsy, WB Saunders, 2000 Pediatric Epilepsy, McGraw-Hill, 2013

    Employment, Commercial Entity:

    1. GSK Pharmaceuticals, speaking engagement, 2009

    Consultancies:

    1. Guidepoint Global, consultant, 2009-2010

    Speakers' Bureaus:

    1. UCB Pharmaceuticals, 2009-2010 GSK Pharmaceuticals, 2009-2010

    Other activities:

    1. Consulatant, The Israel Institute for Medical Assistance, 2009

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Neuropace, 2009-2010 Novartis, 2009-2010 King Pharmaceuticals,2010

    Research Support, Government Entities:

    1. Department of Defense, USAMRAA Grant No. 05098002; Contract No. XWH-06-1-0663, 2007-present

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Bruno Maton, MD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Esperanza Pacheco-Jacome, MD and
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Miami Children Hospital Neuroradiologist

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Gustavo Rey, PhD
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Miami Children's Hospital Clinical Neuropsychologist

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. W81XWH-06-1-0663 Ragheb (PI) 7/2006-Present U. S. Army Medical Research and Materiel Command Traumatic Brain Injury: Multimodal Biomarker Screening Role: Sub-investigator

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Brain Institute (B.K., M.D., G.R.) and Division of Radiology (E.P.-J.), Miami Children's Hospital, FL; Department of Pediatric Neurology (P.K.), Charles University, Prague, Czech Republic; and Division of Neurology (B.M.), Sentara Heart Hospital, Norfolk, VA.
  1. Correspondence to Dr. Korman: bkorman{at}mch.com

Article usage

Article usage: July 2013 to November 2023

AbstractFullPdfSource
Jul 2013267016Highwire
Aug 201311731652Highwire
Sep 2013374624Highwire
Oct 201315824Highwire
Nov 201311957Highwire
Dec 20135113Highwire
Jan 20147414Highwire
Feb 20143402Highwire
Mar 20142812Highwire
Apr 20142611Highwire
May 20142201Highwire
Jun 20142800Highwire
Jul 20142712Highwire
Aug 20142111Highwire
Sep 20142300Highwire
Oct 20141933Highwire
Nov 20141800Highwire
Dec 20142301Highwire
Jan 201510010Highwire
Feb 201515210Highwire
Mar 201510713Highwire
Apr 20155400Highwire
May 20156901Highwire
Jun 20156500Highwire
Jul 20152200Highwire
Aug 20152901Highwire
Sep 20152200Highwire
Oct 20151822Highwire
Nov 20153745Highwire
Dec 2015800Highwire
Jan 20161211Highwire
Feb 20161500Highwire
Mar 20161011Highwire
Apr 20161200Highwire
May 20161400Highwire
Jun 20163000Highwire
Jul 20161700Highwire
Aug 20161702Highwire
Sep 20161700Highwire
Oct 20161000Highwire
Nov 20161300Highwire
Dec 20161600Highwire
Jan 20172000Highwire
Feb 20171401Highwire
Mar 20171812Highwire
Apr 20172200Highwire
May 2017901Highwire
Jun 2017622Highwire
Jul 2017420Highwire
Aug 2017711Highwire
Sep 2017600Highwire
Oct 20171311Highwire
Nov 2017521Highwire
Dec 20171300Highwire
Jan 20181300Highwire
Feb 20181222Highwire
Mar 2018812Highwire
Apr 2018900Highwire
May 20181000Highwire
Jun 2018800Highwire
Jul 20181012Highwire
Aug 20181301Highwire
Sep 2018500Highwire
Oct 20182915Highwire
Nov 20181802Highwire
Dec 2018800Highwire
Jan 20191101Highwire
Feb 20192502Highwire
Mar 20191204Highwire
Apr 20192901Highwire
May 20191513Highwire
Jun 20192212Highwire
Jul 20191101Highwire
Aug 20191400Highwire
Sep 2019701Highwire
Oct 20192303Highwire
Nov 20191500Highwire
Dec 20192415Highwire
Jan 20202206Highwire
Feb 20201904Highwire
Mar 20201723Highwire
Apr 20202716Highwire
May 20201200Highwire
Jun 20201201Highwire
Jul 20201410Highwire
Aug 20201100Highwire
Sep 20201300Highwire
Oct 20201423Highwire
Nov 20201710Highwire
Dec 20201122Highwire
Jan 20211911Highwire
Feb 20212403Highwire
Mar 20211302Highwire
Apr 20211200Highwire
May 20212800Highwire
Jun 20212310Highwire
Jul 20211101Highwire
Aug 20213302Highwire
Sep 20211501Highwire
Oct 20211511Highwire
Nov 20212211Highwire
Dec 20211910Highwire
Jan 20222022Highwire
Feb 20221400Highwire
Mar 20224711Highwire
Apr 20221500Highwire
May 20222700Highwire
Jun 20221133Highwire
Jul 20221912Highwire
Aug 20221000Highwire
Sep 20221000Highwire
Oct 20221510Highwire
Nov 20223832Highwire
Dec 20222001Highwire
Jan 20231400Highwire
Feb 20232610Highwire
Mar 20233101Highwire
Apr 20232111Highwire
May 20232200Highwire
Jun 20231000Highwire
Jul 20232100Highwire
Aug 20232511Highwire
Sep 20231100Highwire
Oct 20231500Highwire
Nov 20231300Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me

Recommended articles